📊PBGC Final Rule Corrections Impacting Employers and Regulations
The Pension Benefit Guaranty Corporation (PBGC) is correcting a final rule that appeared in the Federal Register on August 15, 2025. The document made miscellaneous technical corrections, clarifications, and improvements to PBGC's regulations, including its regulations on premium rates, premium due dates, and termination of single-employer plans.
Learn More💵ICC Application for Clearing Agency Registration Under SEC
The Securities and Exchange Commission is reviewing an application from ICE Clear Credit LLC to register as a clearing agency for U.S. Treasury securities. This application outlines ICC’s proposed operational structure, risk management strategies, and the establishment of a Treasury Guaranty Fund, inviting public comment on the regulatory implications for market participants.
Learn More📈Cboe Introduces All Cancels Report for Enhanced Market Data
The Cboe BYX Exchange is proposing a new All Cancels Report to enhance its existing market data services. This report aims to provide subscribers with comprehensive insights into cancel behavior and messaging activities within the trading environment. By doing so, it seeks to promote transparency and help firms optimize their order management strategies.
Learn More🚫OFAC Sanctions Notice
The U.S. Department of the Treasury's Office of Foreign Assets Control (OFAC) is publishing the names of one or more persons that have been placed on OFAC's Specially Designated Nationals and Blocked Persons List (SDN List) based on OFAC's determination that one or more applicable legal criteria were satisfied. All property and interests in property subject to U.S. jurisdiction of these persons are blocked, and U.S. persons are generally prohibited from engaging in transactions with them.
Learn More🇨🇺New Regulations Impacting U.S. Businesses in Cuba
This memorandum reissues and amends National Security Presidential Memorandum 5, focusing on strengthening U.S. policy toward Cuba through financial transaction restrictions, supporting human rights and democracy, and ensuring that U.S. interests align with engagement policies relating to Cuba's government and populace.
Learn More📊SEC Notice on Paxos Clearing Agency Application Impacts
Paxos Securities Settlement Company, LLC has filed an application with the SEC for registration as a clearing agency. The application details its intended services, including clearance and settlement through a private, permissioned settlement service using distributed ledger technology. The SEC is soliciting comments on this application as part of its review process.
Learn More🎓Updates to Income-Contingent Repayment Plan for 2025 Announced
The Secretary announces the annual updates to the ICR plan formula for 2025 to give notice to borrowers and the public regarding how monthly ICR payment amounts will be calculated for the 2025-2026 year under the William D. Ford Federal Direct Loan (Direct Loan) Program, Assistance Listing Number 84.063.
Learn More📈Proposed Rule Change for Commodity-Based Trust Shares by NYSE
The Securities and Exchange Commission has published a notice for NYSE Arca's proposed rule change to establish new generic listing standards for Commodity-Based Trust Shares. This rule aims to streamline the trading process, enhance market efficiency, and support investor protection by reducing costs and time associated with getting new securities to market. The proposed regulations outline criteria and definitions crucial for compliance within the trading landscape.
Learn More📈Nasdaq BX Proposes New Options Regulatory Fee Structure
Nasdaq BX has filed a proposed rule change to modify the Options Regulatory Fee (ORF) methodology, focusing on transactions executed and cleared within its exchange. This change, effective January 2, 2026, aims to align regulatory costs with the financial activities of market participants while continuing to monitor revenue generation from the ORF to ensure it does not exceed regulatory costs.
Learn More💰FDA Announces Animal Drug User Fee Rates for FY 2026
The Food and Drug Administration (FDA, the Agency, or we) is announcing the fee rates and payment procedures for fiscal year (FY) 2026 animal drug user fees. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Animal Drug User Fee Amendments of 2023 (ADUFA V), authorizes FDA to collect user fees for certain animal drug applications and supplemental animal drug applications, for certain animal drug products, for certain establishments where such products are made, and for certain sponsors of such animal drug applications and/or investigational animal drug submissions. This notice establishes the fee rates for FY 2026.
Learn More